Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 1... von Reich, K., Warren, R.B., Iversen, L., Puig, L., Pau‐Charles, I., Igarashi, A., Ohtsuki, M., Falqués, M., Harmut, M., Rozzo, S., Lebwohl, M.G., Cantrell, W., Blauvelt, A., Thaçi, D.

Volltext

A study of the drug tildrakizumab in psoriasis patients von Reich, K., Warren, R.B., Iversen, L., Puig, L., Pau‐Charles, I., Igarashi, A., Ohtsuki, M., Falqués, M., Harmut, M., Rozzo, S., Lebwohl, M.G., Cantrell, W., Blauvelt, A., Thaçi, D.

Volltext

Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (re... von Thaci, D., Piaserico, S., Warren, R.B., Gupta, A.K., Cantrell, W., Draelos, Z., Foley, P., Igarashi, A., Langley, R.G., Asahina, A., Young, M., Falqués, M., Pau‐Charles, I., Mendelsohn, A.M., Rozzo, S.J., Reich, K.

Volltext

Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial von Piraccini, B.M., Blume‐Peytavi, U., Scarci, F., Jansat, J.M., Falqués, M., Otero, R., Tamarit, M.L., Galván, J., Tebbs, V., Massana, E.

Volltext

Cost-Effectiveness of Linaclotide Compared to Antidepressants in the Treatment of Irritable Bowel Syndrome with Constipation in Scotland von Fisher, M, Falqués, M, Rance, M, Taylor, D.C.A, Lindner, L

Volltext

Use of reflectance confocal microscopy to evaluate 5‐fluorouracil 0.5%/salicylic acid 10% in the field‐directed treatment of subclinical lesions of actinic keratosis: subanalysis o... von Ulrich, M., Reinhold, U., Falqués, M., Rodriguez Azeredo, R., Stockfleth, E.

Volltext

一项在银屑病患者中开展的 tildrakizumab 药物研究 von Reich, K., Warren, R.B., Iversen, L., Puig, L., Pau‐Charles, I., Igarashi, A., Ohtsuki, M., Falqués, M., Harmut, M., Rozzo, S., Lebwohl, M.G., Cantrell, W., Blauvelt, A., Thaçi, D.

Volltext

Randomised clinical trials: linaclotide phase 3 studies in IBS‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints von Quigley, E. M. M., Tack, J., Chey, W. D., Rao, S. S., Fortea, J., Falques, M., Diaz, C., Shiff, S. J., Currie, M. G., Johnston, J. M.

Volltext

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan von Goadsby, PJ, Zanchin, G, Geraud, G, de Klippel, N, Diaz-Insa, S, Gobel, H, Cunha, L, Ivanoff, N, Falques, M, Fortea, J

Volltext

Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study von Kerkhof, P.C.M., Loewe, R., Mrowietz, U., Falques, M., Pau‐Charles, I., Szepietowski, J.C.

Volltext

一项在银屑病患者中开展的 tildrakizumab 药物研究 von Reich, K., Warren, R.B., Iversen, L., Puig, L., Pau‐Charles, I., Igarashi, A., Ohtsuki, M., Falqués, M., Harmut, M., Rozzo, S., Lebwohl, M.G., Cantrell, W., Blauvelt, A., Thaçi, D.

Volltext

PWE-175 Cost-effectiveness Of Linaclotide (lin) Compared To Antidepressants (atds) In The Treatment Of Irritable Bowel Syndrome With Constipation (ibs-c) In Scotland von Fisher, M, Walker, A, Falqués, M, Rance, M, Taylor, D, Lindner, L

Volltext

PGI27 - Cost-Effectiveness of Linaclotide Compared to Antidepressants in the Treatment of Irritable Bowel Syndrome with Constipation in Scotland von Fisher, M., Falqués, M., Rance, M., Taylor, D.C.A., Lindner, L.

Volltext

Peak inspiratory flow through the Genuair® inhaler in patients with moderate or severe COPD von Magnussen, H, Watz, H, Zimmermann, I, Macht, S, Greguletz, R, Falques, M, Jarreta, D, Garcia Gil, E

Volltext

Efficacy of Aclidinium Bromide 400 μg Twice Daily Compared With Placebo and Tiotropium in Patients With Moderate to Severe COPD von Fuhr, Rainard, MD, PhD, Magnussen, Helgo, MD, Sarem, Kristina, MD, Llovera, Anna Ribera, PharmD, PhD, Kirsten, Anne-Marie, MD, Falqués, Meritxell, MS, Caracta, Cynthia F., MD, FCCP, Garcia Gil, Esther, MD

Volltext

PTU-187 Sample size calculation in confirmatory trials in irritable bowel syndrome with constipation: experience with linaclotide (constella®) von Falques, M, Díaz, C, Vilardell, D, tea, J, Johnston, JM

Volltext

PTU-186 Baseline characteristics as a predictor of response to linaclotide (constella®) in patients with irritable bowel syndrome with constipation: a pooled analysis of 2 phase 3... von Díaz, C, Falques, M, Vilardell, D, Fortea, J, Johnston, JM

Volltext

PTU-187 Sample size calculation in confirmatory trials in irritable bowel syndrome with constipation: experience with linaclotide (constella®): Abstract PTU-187 Table 1 von Falques, M, Díaz, C, Vilardell, D, Fortea, J, Johnston, JM

Volltext

PTU-188 Statistical approaches to missing data in trials of irritable bowel syndrome with constipation: experience with linaclotide (constella®) von Falques, M, Díaz, C, Vilardell, D, tea, J, Johnston, JM

Volltext

PTU-188 Statistical approaches to missing data in trials of irritable bowel syndrome with constipation: experience with linaclotide (constella®): Abstract PTU-188 Table 1 von Falques, M, Díaz, C, Vilardell, D, Fortea, J, Johnston, JM

Volltext